2015 Quality Performance Results

  2015 reporting period
Measure numberMeasure NameACO performance rateMean performance rate (SSP- ACOs)
ACO-1CAHPS: Getting Timely Care, Appointments, and Information81.1280.61
ACO-2CAHPS: How Well Your Providers Communicate90.7692.65
ACO-3CAHPS: Patients’ Rating of Provider90.3891.94
ACO-4CAHPS: Access to Specialists82.0383.61
ACO-5CAHPS: Health Promotion and Education62.0459.06
ACO-6CAHPS: Shared Decision Making74.3775.17
ACO-7CAHPS: Health Status/Functional Status70.5572.3
ACO-34CAHPS: Stewardship of Patient Resources*30.7126.87
ACO-8Risk Standardized, All Condition Readmission14.5814.86
ACO-35Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission18.2418.07
ACO-36All-Cause Unplanned Admissions for Patients with Diabetes*50.5454.6
ACO-37All-Cause Unplanned Admissions for Patients with Heart Failure*77.1176.96
ACO-38All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions65.7562.92
ACO-9Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)1.111.11
ACO-10Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)1.231.04
ACO-11Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements10080.14
ACO-39Documentation of Current Medications in the Medical Record*92.1184.07
ACO-13Falls: Screening for Future Fall Risk91.1656.46
ACO-14Preventive Care and Screening: Influenza Immunization73.3162.03
ACO-15Pneumonia Vaccination Status for Older Adults88.0563.73
ACO-16Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up57.0971.15
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention99.2890.16
ACO-18Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan85.9445.25
ACO-19Colorectal Cancer Screening79.0360.06
ACO-20Breast Cancer Screening81.5365.67
ACO-21Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented72.5170.04
ACO-40Depression Remission at Twelve Months*N/AN/A
ACO-27Diabetes Mellitus: Hemoglobin A1c Poor Control14.4620.38
ACO-41Diabetes: Eye Exam*70.2841.06
ACO-28Hypertension: Controlling High Blood Pressure74.7069.62
ACO-30Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic89.6883.82
ACO-31Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)96.6387.22
ACO-33Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)83.8177.73
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A